CAP Comments on CMS Antifraud Efforts, Urges Reevaluation of MolDX Program
The College of American Pathologists (CAP) submitted comments in response to a request for information on the Centers for Medicare & Medicaid...
The Centers for Medicare & Medicaid Services (CMS) recently clarified Clinical Laboratory Improvement Act (CLIA) certification requirements for remote cytology.
The College of American Pathologists (CAP) requested clarification because of recent federal policy updates, including updates to requirements related to CLIA certification for laboratories. CMS officials explained that remote Rapid Adequacy Assessments (also known as rapid on-site evaluation or ROSE) require a separate CLIA certificate for an off-site location where a review is performed, including virtual slide review. CMS also clarified that adequacy assessment does not count as a separate examination for workload limit purposes.
Source:
https://www.cap.org/advocacy/latest-news-and-practice-data/march-31-2026#story2
The College of American Pathologists (CAP) submitted comments in response to a request for information on the Centers for Medicare & Medicaid...
Lincoln, NE — April 1, 2026 — TELCOR Inc, a leading provider of healthcare technology solutions for laboratories and healthcare facilities, today...
The Centers for Medicare & Medicaid Services (CMS) issued a final rule on national standards for electronic claims attachments and signatures,...